These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 25159041)

  • 1. Drugs and drug intermediates from fungi: Striving for greener processes.
    Sharma M; Sharma R
    Crit Rev Microbiol; 2016; 42(2):322-38. PubMed ID: 25159041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fungal biodiversity to biotechnology.
    Chambergo FS; Valencia EY
    Appl Microbiol Biotechnol; 2016 Mar; 100(6):2567-77. PubMed ID: 26810078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Microbial drugs: captured again as S&T spotlight: To the special issue "Innovation & Highly Efficient Production of Microbial Drugs"].
    Bai L; Deng Z
    Wei Sheng Wu Xue Bao; 2016 Mar; 56(3):i-iii. PubMed ID: 27382777
    [No Abstract]   [Full Text] [Related]  

  • 4. Biodiversity, chemical diversity and drug discovery.
    Singh SB; Pelaez F
    Prog Drug Res; 2008; 65():141, 143-74. PubMed ID: 18084915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization and control of fungal morphology for improved production performance in biotechnology.
    Krull R; Wucherpfennig T; Esfandabadi ME; Walisko R; Melzer G; Hempel DC; Kampen I; Kwade A; Wittmann C
    J Biotechnol; 2013 Jan; 163(2):112-23. PubMed ID: 22771505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mycotechnology: the role of fungi in biotechnology.
    Bennett JW
    J Biotechnol; 1998 Dec; 66(2-3):101-7. PubMed ID: 9866863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Progress in heterologous expression of fungal natural products-A review].
    Ma Z; Li W; Yin W
    Wei Sheng Wu Xue Bao; 2016 Mar; 56(3):429-40. PubMed ID: 27382786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biocatalysis: synthesis of chiral intermediates for drugs.
    Patel RN
    Curr Opin Drug Discov Devel; 2006 Nov; 9(6):741-64. PubMed ID: 17117684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploitation of Fungal Biodiversity for Discovery of Novel Antibiotics.
    Karwehl S; Stadler M
    Curr Top Microbiol Immunol; 2016; 398():303-338. PubMed ID: 27422786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biosynthesis of hydrocarbons and volatile organic compounds by fungi: bioengineering potential.
    Spakowicz DJ; Strobel SA
    Appl Microbiol Biotechnol; 2015 Jun; 99(12):4943-51. PubMed ID: 25957494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biocatalysis for the synthesis of pharmaceuticals and pharmaceutical intermediates.
    Sun H; Zhang H; Ang EL; Zhao H
    Bioorg Med Chem; 2018 Apr; 26(7):1275-1284. PubMed ID: 28709846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microbial Bioconversion: A Regio-specific Method for Novel Drug Design and Toxicological Study of Metabolites.
    Yousuf M; Jamil W; Mammadova K
    Curr Pharm Biotechnol; 2019; 20(14):1156-1162. PubMed ID: 31258075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioengineering tools for the production of pharmaceuticals: current perspective and future outlook.
    Sarsaiya S; Shi J; Chen J
    Bioengineered; 2019 Dec; 10(1):469-492. PubMed ID: 31656120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring fungal biodiversity for the production of water-soluble pigments as potential natural food colorants.
    Mapari SA; Nielsen KF; Larsen TO; Frisvad JC; Meyer AS; Thrane U
    Curr Opin Biotechnol; 2005 Apr; 16(2):231-8. PubMed ID: 15831392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microbial/enzymatic synthesis of chiral pharmaceutical intermediates.
    Patel RN
    Curr Opin Drug Discov Devel; 2003 Nov; 6(6):902-20. PubMed ID: 14758760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production of drugs by microbial biosynthesis and biotransformation. Possibilities, limits and future developments (1st communication).
    Kieslich K
    Arzneimittelforschung; 1986 Apr; 36(4):774-8. PubMed ID: 3718602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biocatalysis for synthesis of pharmaceuticals.
    Patel RN
    Bioorg Med Chem; 2018 Apr; 26(7):1252-1274. PubMed ID: 28648492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Synthetic biology toward microbial secondary metabolites and pharmaceuticals].
    Wu LZ; Hong B
    Yao Xue Xue Bao; 2013 Feb; 48(2):155-60. PubMed ID: 23672010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fungal genetics, genomics, and secondary metabolites in pharmaceutical sciences.
    Misiek M; Hoffmeister D
    Planta Med; 2007 Feb; 73(2):103-15. PubMed ID: 17245664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biodiversity in production of antibiotics and other bioactive compounds.
    Mahajan G; Balachandran L
    Adv Biochem Eng Biotechnol; 2015; 147():37-58. PubMed ID: 24840777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.